SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential. (Q54456401)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Yu-Feng Tian

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Tzu-Ju Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Ching-Yih Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Li-Tzong Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Li-Ching Lin

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Chung-Hsi Hsing

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Sung-Wei Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Ming-Jen Sheu

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Hao-Hsien Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Yow-Ling Shiue

10

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Hsuan-Ying Huang

11

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Hsin-Yi Pan

12

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Chien-Feng Li

13

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Shang-Hung Chen

14

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

publication date

18 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

34

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

1107-1117

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Overexpression of SKP2 promotes the radiation resistance of esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Skp2 is oncogenic and overexpressed in human cancers

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

5-Fluorouracil: mechanisms of action and clinical strategies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0652-Z

21 January 2018

Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23328995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23328995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23328995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathological features of rectal cancer after preoperative radiochemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23328995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23328995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03

1 reference

https://pubmed.ncbi.nlm.nih.gov/23328995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-0652-Z

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23328995

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54456401&oldid=2212475050"